Citation Tools

Download PDFPDF

Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials

Download to a citation manager

Cite this article as:
Kaufman HL, Andtbacka RHI, Collichio FA, et al
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials